| Stock | Price | 52 Week Range | Marketcap | EPS | Dividend Yield | Chart (24H) | Sector | Employees | Last Updated |
|---|---|---|---|---|---|---|---|---|---|
 280585 AHS | $0.0000 | 0.0000 | 0.00 | 0.00% | 0 | 6 years ago | |||
| $0.0000 | 0.0000 | 0.00 | 0.00% | 0 | 6 years ago | ||||
| $6.94 | 88.67M | 0.80 | 0.00% | Energy | 681 | 9 hours ago | |||
| $0.0000 | 0.0000 | 0.00 | 0.00% | 0 | 6 years ago | ||||
| $7.04 | 208.80M | 1.23 | 11.36% | Real Estate | 0 | 9 hours ago | |||
 756474 PRX | $0.0000 | 0.0000 | 0.00 | 0.00% | 0 | 6 years ago | |||
| $32.88 | 921.48M | 0.21 | 4.14% | Consumer Cyclical | 5,700 | 9 hours ago |
The stock market can feel like an unending maze, but what if you could cut straight to the goldmine? Louis Navellier’s proprietary Portfolio Grader has done just that, distilling over 4,000 stocks down to an elite group of eight—each receiving top marks in Total Grade, Overall Fundamental Grade, and Quantitative Grade. These aren’t just any stocks; these are the cream of the crop, the ‘Triple A’ picks guaranteed to make heads turn.
For active investors, this handpicked list provides precision and unbeatable potential. With rock-solid fundamentals, stellar growth metrics, and a proven record of outpacing the S&P 500, these stocks are poised to skyrocket. Let’s delve into these unmatched investment gems.
Editor's Note: Analysis and insight for this article were originally sourced sourced from our friends at InvestorPlace
AMN Healthcare (NYSE: AHS)
Healthcare at the Forefront
First on our elite roster is AMN Healthcare, a titan in healthcare staffing. Whether recruiting nurses, physicians, or healthcare professionals for temporary or permanent roles, AMN Healthcare is the go-to. YTD, AHS has shot up by a staggering 25.7%, outperforming the S&P 500’s modest 12.9% increase.
Demand Driving Success
The ongoing global healthcare challenge has amplified the demand for healthcare services exponentially. AMN Healthcare rises to meet this need, making it an irresistible buy. With its solid performance and growth trajectory, AHS is your ticket to tapping into the robust healthcare market.
Analyst Ratings and Forecasts
| Metric | Value |
| Consensus Rating | Overweight |
| Average Price Target | $83.33 |
| Potential Gain | 14.1% |
| Number of Ratings | 7 |
Summary of Analysts’ Outlook:
Analysts have a positive outlook on AMN Healthcare, with a consensus rating of Overweight. The average price target of $83.33 suggests a potential gain of 14.1%. This optimism stems from the company’s strong financial performance, growth prospects, and solid execution.
Alon USA Energy (NYSE: ALJ)
Powering the Future
Next, we spotlight Alon USA Energy—a formidable independent refiner and marketer of petroleum products. Operating in essential U.S. regions, Alon has seen its stock rise by 11.4% since January 1, 2013. This impressive gain underscores the company’s resilience in the dynamic energy sector.
Operational Resiliency
As demand for energy fuels the market, Alon USA Energy’s strategic position ensures it thrives. The stock’s performance signals a stellar opportunity for future growth, making ALJ a must-have for energy sector enthusiasts.
Analyst Ratings and Forecasts
| Metric | Value |
| Consensus Rating | Hold |
| Average Price Target | $24.50 |
| Potential Gain | 14.1% |
| Number of Ratings | 5 |
Summary of Analysts’ Outlook:
Analysts have a mixed outlook on Alon USA Energy, with 2 Buy ratings, 2 Hold ratings, and 1 Sell rating. The average price target suggests a potential upside of 14.1%. While some analysts see value in the company’s refining and logistics operations, others are concerned about the competitive landscape and regulatory headwinds.
Geospace Technologies Corp. (NASDAQ: GEOS)
Innovation Meets Energy
Geospace Technologies Corp. is a standout, merging the domains of technology and energy. Specializing in seismic data acquisition and processing instruments, GEOS meets critical needs in oil and gas reservoir monitoring. Despite a modest 0.8% increase since the start of the year, its strategic importance can’t be overstated.
Seismic Opportunities
As exploration and production activities continue, the demand for advanced seismic equipment will rise. Geospace’s innovative prowess and strategic market position make it a stock to watch as the energy-tech sector evolves.
Analyst Ratings and Forecasts
| Metric | Value |
| Consensus Rating | Hold |
| Average Price Target | $14.50 |
| Potential Gain | 21.1% |
| Number of Ratings | 4 |
Summary of Analysts’ Outlook:
Analysts have a mixed outlook on GEOS, with 2 out of 4 analysts rating it as a “Hold” and 2 rating it as a “Buy”. The average price target suggests a potential gain of 21.1%. Analysts’ sentiments range from neutral to slightly bullish, highlighting both potential and caution.
Liberty Media Corp. Class A (NASDAQ: LMCA)
Diverse Media Mastery
Liberty Media Corp. is a diversified behemoth with interests spread across media, communications, and entertainment. Liberty’s robust portfolio provides multi-sector growth opportunities, making it an indispensable investment.
Adaptable and Resilient
Liberty Media’s broad exposure allows it to swiftly capitalize on evolving market trends, thereby maximizing returns. LMCA’s scale and diversified revenue streams make it a correlated play across varied sectors, promising resilience and profitability.
Analyst Ratings and Forecast
| Metric | Value |
| Consensus Rating | Overweight |
| Average Price Target | $54.33 |
| Potential Gain | 24.1% |
| Number of Ratings | 6 |
Summary of Analysts’ Outlook:
Analysts have a positive outlook on Liberty Media, with a consensus rating of Overweight. The average price target of $54.33 suggests a potential gain of 24.1%. This indicates belief in the stock’s room for growth, making it a compelling investment opportunity.
AG Mortgage Investment Trust Inc. (NYSE: MITT)
Real Estate Riches
AG Mortgage Investment Trust is a commanding presence in residential mortgage assets and related securities. Rising by 9.8% since the start of the year, coupled with an attractive 3.2% dividend yield and a trailing PE Ratio of 3.70, MITT is a powerhouse.
Steady Income and Growth
In a low-interest climate, the combination of income and capital appreciation that real estate investments offer is unparalleled. MITT is a dynamo, providing a lucrative blend of stable dividends and substantial growth potential.
Analyst Ratings and Forecasts
| Metric | Value |
| Consensus Rating | Hold |
| Average Price Target | $14.50 |
| Potential Gain | 15.1% |
| Number of Ratings | 6 |
Summary of Analysts’ Outlook:
Analysts have a neutral outlook on AG Mortgage Investment Trust, with a consensus rating of Hold. The average price target of $14.50 suggests a potential gain of 15.1%. Analysts note the company’s diversified portfolio and strong liquidity, though some express concerns over rising interest rates.
Par Pharmaceutical (NYSE: PRX)
Affordable Healthcare Heroes
Par Pharmaceutical is at the forefront of the generic and branded pharmaceutical industry. Leveraging its prowess in development, manufacturing, and distribution, PRX is perfectly aligned with the increasing push towards affordable healthcare.
Pharma Prowess
Par Pharmaceutical’s robust fundamentals and strategic market positioning ensure that it meets the rising demand for cost-effective healthcare solutions. PRX is a pharmaceutical stock with substantial long-term potential.
Analyst Ratings and Forecasts
| Metric | Value |
| Consensus Rating | Overweight |
| Average Price Target | $134.15 |
| Potential Gain | 14.1% |
| Number of Ratings | 13 |
Summary of Analysts’ Outlook:
Analysts have a positive outlook on Par Pharmaceutical, with a consensus rating of Overweight. The average price target of $134.15 implies a potential gain of 14.1%. Strong fundamentals, market leadership, and growth through innovation and acquisitions drive analyst optimism.
Winnebago Industries (NYSE: WGO)
Adventure Awaits
Finally, we turn to Winnebago Industries, a leading manufacturer of self-contained recreational vehicles (RVs). The stock price has soared by 22% in 2013, thanks in part to a robust PE Ratio of 8.80.
On the Road to Triumph
With the surge in outdoor recreational activities, Winnebago is perfectly poised to capitalize on this trend. Its stellar performance reflects a promising future, making it a standout in the lifestyle investment arena.
Analyst Ratings and Forecasts
| Metric | Value |
| Consensus Rating | Overweight (Buy) |
| Average Price Target | $83.50 |
| Potential Gain | 14.1% |
| Number of Ratings | 7 |
Summary of Analysts’ Outlook:
Analysts have a positive outlook on Winnebago, with a consensus rating of Overweight (Buy). The average price target suggests a potential gain of 14.1%. Analysts praise the company’s strong financial performance and growth initiatives within the thriving RV market.
Louis Navellier’s Portfolio Grader has unearthed an elite group of ‘Triple A’ stocks, each showcasing substantial prowess across various powerhouse sectors. If you’re seeking to elevate your portfolio to new heights, these stocks deserve your attention. Seize these opportunities and watch your investments thrive.
